Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by molybuckson Jun 05, 2009 1:26pm
457 Views
Post# 16047510

Weak Hands

Weak Hands
Relax, Penny flippers bailing out. On to manipulate another stock......good ridance I say. Nothing has changed with respect to what is going to happen to this stock and its future going forward. Big pharma is looking to get into stem cell in a bad way and we have the goods. Patience will be rewarded in the coming month or two.

Cheers, Molybucks
Bullboard Posts